Logo image of CRWS

CROWN CRAFTS INC (CRWS) Stock Fundamental Analysis

NASDAQ:CRWS - Nasdaq - US2283091005 - Common Stock - Currency: USD

4.49  -0.03 (-0.66%)

Fundamental Rating

4

CRWS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CRWS has only an average score on both its financial health and profitability. CRWS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CRWS had positive earnings in the past year.
CRWS had a positive operating cash flow in the past year.
Each year in the past 5 years CRWS has been profitable.
In the past 5 years CRWS always reported a positive cash flow from operatings.
CRWS Yearly Net Income VS EBIT VS OCF VS FCFCRWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.27%, CRWS is in line with its industry, outperforming 57.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.38%, CRWS is in line with its industry, outperforming 55.10% of the companies in the same industry.
CRWS's Return On Invested Capital of 4.62% is in line compared to the rest of the industry. CRWS outperforms 42.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRWS is in line with the industry average of 11.36%.
The 3 year average ROIC (10.30%) for CRWS is well above the current ROIC(4.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.27%
ROE 6.38%
ROIC 4.62%
ROA(3y)9.54%
ROA(5y)10.13%
ROE(3y)14.23%
ROE(5y)14.56%
ROIC(3y)10.3%
ROIC(5y)11.87%
CRWS Yearly ROA, ROE, ROICCRWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CRWS has a Profit Margin (3.73%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CRWS has declined.
Looking at the Operating Margin, with a value of 5.57%, CRWS is in line with its industry, outperforming 48.98% of the companies in the same industry.
CRWS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 25.94%, CRWS is not doing good in the industry: 83.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRWS has declined.
Industry RankSector Rank
OM 5.57%
PM (TTM) 3.73%
GM 25.94%
OM growth 3Y-14.01%
OM growth 5Y-15.07%
PM growth 3Y-10.16%
PM growth 5Y-3.12%
GM growth 3Y-4.81%
GM growth 5Y-2.1%
CRWS Yearly Profit, Operating, Gross MarginsCRWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

CRWS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRWS has more shares outstanding
Compared to 5 years ago, CRWS has more shares outstanding
CRWS has a better debt/assets ratio than last year.
CRWS Yearly Shares OutstandingCRWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CRWS Yearly Total Debt VS Total AssetsCRWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CRWS has an Altman-Z score of 2.25. This is not the best score and indicates that CRWS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.25, CRWS is doing worse than 67.35% of the companies in the same industry.
CRWS has a debt to FCF ratio of 2.37. This is a good value and a sign of high solvency as CRWS would need 2.37 years to pay back of all of its debts.
CRWS has a better Debt to FCF ratio (2.37) than 61.22% of its industry peers.
CRWS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.37, CRWS perfoms like the industry average, outperforming 51.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 2.37
Altman-Z 2.25
ROIC/WACC0.54
WACC8.54%
CRWS Yearly LT Debt VS Equity VS FCFCRWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.3 Liquidity

CRWS has a Current Ratio of 3.32. This indicates that CRWS is financially healthy and has no problem in meeting its short term obligations.
CRWS's Current ratio of 3.32 is amongst the best of the industry. CRWS outperforms 87.76% of its industry peers.
A Quick Ratio of 1.51 indicates that CRWS should not have too much problems paying its short term obligations.
CRWS's Quick ratio of 1.51 is fine compared to the rest of the industry. CRWS outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.51
CRWS Yearly Current Assets VS Current LiabilitesCRWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

The earnings per share for CRWS have decreased strongly by -26.53% in the last year.
The Earnings Per Share has been decreasing by -0.85% on average over the past years.
The Revenue has been growing slightly by 6.42% in the past year.
Measured over the past years, CRWS shows a small growth in Revenue. The Revenue has been growing by 2.78% on average per year.
EPS 1Y (TTM)-26.53%
EPS 3Y-13.99%
EPS 5Y-0.85%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)6.42%
Revenue growth 3Y3.43%
Revenue growth 5Y2.78%
Sales Q2Q%1.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRWS Yearly Revenue VS EstimatesCRWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRWS Yearly EPS VS EstimatesCRWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.82, the valuation of CRWS can be described as reasonable.
CRWS's Price/Earnings ratio is rather cheap when compared to the industry. CRWS is cheaper than 83.67% of the companies in the same industry.
CRWS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.12.
Industry RankSector Rank
PE 11.82
Fwd PE N/A
CRWS Price Earnings VS Forward Price EarningsCRWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

91.84% of the companies in the same industry are more expensive than CRWS, based on the Enterprise Value to EBITDA ratio.
CRWS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRWS is cheaper than 91.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.34
EV/EBITDA 5.1
CRWS Per share dataCRWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.11%, CRWS is a good candidate for dividend investing.
CRWS's Dividend Yield is rather good when compared to the industry average which is at 2.75. CRWS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, CRWS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

The dividend of CRWS decreases each year by -0.23%.
CRWS has been paying a dividend for at least 10 years, so it has a reliable track record.
CRWS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years2
CRWS Yearly Dividends per shareCRWS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

CRWS pays out 100.74% of its income as dividend. This is not a sustainable payout ratio.
CRWS's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP100.74%
EPS Next 2YN/A
EPS Next 3YN/A
CRWS Yearly Income VS Free CF VS DividendCRWS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CRWS Dividend Payout.CRWS Dividend Payout, showing the Payout Ratio.CRWS Dividend Payout.PayoutRetained Earnings

CROWN CRAFTS INC

NASDAQ:CRWS (2/7/2025, 8:21:26 PM)

4.49

-0.03 (-0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-05 2025-02-05
Earnings (Next)06-26 2025-06-26
Inst Owners35.57%
Inst Owner Change0.07%
Ins Owners9%
Ins Owner Change10.6%
Market Cap46.65M
Analysts43.33
Price TargetN/A
Short Float %0.24%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly Dividend0.32
Dividend Growth(5Y)-0.23%
DP100.74%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.82
Fwd PE N/A
P/S 0.54
P/FCF 5.34
P/OCF 4.93
P/B 0.92
P/tB 1.58
EV/EBITDA 5.1
EPS(TTM)0.38
EY8.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.84
FCFY18.74%
OCF(TTM)0.91
OCFY20.29%
SpS8.38
BVpS4.89
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 6.38%
ROCE 6%
ROIC 4.62%
ROICexc 4.74%
ROICexgc 6.49%
OM 5.57%
PM (TTM) 3.73%
GM 25.94%
FCFM 10.04%
ROA(3y)9.54%
ROA(5y)10.13%
ROE(3y)14.23%
ROE(5y)14.56%
ROIC(3y)10.3%
ROIC(5y)11.87%
ROICexc(3y)10.57%
ROICexc(5y)12.09%
ROICexgc(3y)12.94%
ROICexgc(5y)15.32%
ROCE(3y)13.36%
ROCE(5y)15.39%
ROICexcg growth 3Y-26.44%
ROICexcg growth 5Y-22.47%
ROICexc growth 3Y-23.98%
ROICexc growth 5Y-19.71%
OM growth 3Y-14.01%
OM growth 5Y-15.07%
PM growth 3Y-10.16%
PM growth 5Y-3.12%
GM growth 3Y-4.81%
GM growth 5Y-2.1%
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 2.37
Debt/EBITDA 1.46
Cap/Depr 8.97%
Cap/Sales 0.83%
Interest Coverage 7.24
Cash Conversion 73.43%
Profit Quality 269.51%
Current Ratio 3.32
Quick Ratio 1.51
Altman-Z 2.25
F-Score4
WACC8.54%
ROIC/WACC0.54
Cap/Depr(3y)42.84%
Cap/Depr(5y)44.23%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)109.45%
Profit Quality(5y)115.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-26.53%
EPS 3Y-13.99%
EPS 5Y-0.85%
EPS Q2Q%-22.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.42%
Revenue growth 3Y3.43%
Revenue growth 5Y2.78%
Sales Q2Q%1.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.48%
EBIT growth 3Y-11.06%
EBIT growth 5Y-12.7%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.76%
FCF growth 3Y-7.7%
FCF growth 5Y-5.19%
OCF growth 1Y22.43%
OCF growth 3Y-6.76%
OCF growth 5Y-4.61%